Synthetic Lethality in ERCC1-deficient Non-Small Cell Lung Cancer

被引：0
|
作者：
Postel-Vinay, S. [1 ]
Bajrami, I. [2 ]
Friboulet, L. [1 ]
Jaco, I. [2 ]
Fontebasso, Y. [2 ]
Olaussen, K. A. [1 ]
Soria, J. C. [3 ]
Andre, F. [1 ]
Lord, C. J. [2 ]
Ashworth, A. [2 ]
机构：
[1] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France
[2] Breakthrough Breast Canc Ctr, Inst Canc Res, London, England
[3] Univ Paris 11, Dept Med, Inst Gustave Roussy, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72086-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
288
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
    Chabanon, Roman M.
    Muirhead, Gareth
    Krastev, Dragomir B.
    Adam, Julien
    Morel, Daphne
    Garrido, Marlene
    Lamb, Andrew
    Henon, Clemence
    Dorvault, Nicolas
    Rouanne, Mathieu
    Marlow, Rebecca
    Bajrami, Ilirjana
    Cardenosa, Marta Llorca
    Konde, Asha
    Besse, Benjamin
    Ashworth, Alan
    Pettitt, Stephen J.
    Haider, Syed
    Marabelle, Aurelien
    Tutt, Andrew N. J.
    Soria, Jean-Charles
    Lord, Christopher J.
    Postel-Vinay, Sophie
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (03): : 1211 - 1228
  • [2] A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer
    S Postel-Vinay
    I Bajrami
    L Friboulet
    R Elliott
    Y Fontebasso
    N Dorvault
    K A Olaussen
    F André
    J-C Soria
    C J Lord
    A Ashworth
    Oncogene, 2013, 32 : 5377 - 5387
  • [3] A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer
    Postel-Vinay, S.
    Bajrami, I.
    Friboulet, L.
    Elliott, R.
    Fontebasso, Y.
    Dorvault, N.
    Olaussen, K. A.
    Andre, F.
    Soria, J-C
    Lord, C. J.
    Ashworth, A.
    ONCOGENE, 2013, 32 (47) : 5377 - 5387
  • [4] The effect of PARP inhibition on BAX/BAK independent synthetic lethality of BRCA1-deficient non-small cell lung cancer
    Paul, I.
    Savage, K.
    Lamers, E.
    Gately, K.
    O'Byrne, K. J.
    Blayney, J. K.
    Kerr, K. M.
    Sheaff, M.
    Richard, D. J.
    Hamilton, P. W.
    James, J.
    Quinn, J. E.
    Fennell, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] PARP INHIBITION INDUCES BAX/BAK INDEPENDENT SYNTHETIC LETHALITY OF BRCA1-DEFICIENT NON-SMALL CELL LUNG CANCER
    Paul, Ian
    Savage, Kienan I.
    Blainey, Jaine
    Lamers, Elisabeth
    Gately, Kathy
    Kerr, Keith M.
    Sheaff, Michael
    Richard, Derek J.
    Hamilton, Peter
    James, Jackie
    O'Byrne, Kenneth J.
    Harkin, Paul
    Quinn, Jennifer E.
    Fennell, Dean A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S423 - S424
  • [6] PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer
    Paul, Ian
    Savage, Kienan I.
    Blayney, Jaine K.
    Lamers, Elisabeth
    Gately, Kathy
    Kerr, Keith
    Sheaff, Michael
    Arthur, Kenneth
    Richard, Derek J.
    Hamilton, Peter W.
    James, Jacqueline A.
    O'Byrne, Kenneth J.
    Harkin, D. Paul
    Quinn, Jennifer E.
    Fennell, Dean A.
    JOURNAL OF PATHOLOGY, 2011, 224 (04): : 564 - 574
  • [7] ERCC1 expression in non-small cell lung cancers
    Bilello, S. J.
    Walter, A.
    Volodin, L.
    Mills, G.
    Lowery-Nordberg, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 688 - 688
  • [8] Expression of ERCC1 and its clinicopathological correlations in non-small cell lung cancer
    Emre Tepeli
    Vildan Caner
    Nur Büyükpınarbaşılı
    G. Ozan Çetin
    Füsun Düzcan
    Levent Elmas
    Gülseren Bağcı
    Molecular Biology Reports, 2012, 39 : 335 - 341
  • [9] Expression of ERCC1 and its clinicopathological correlations in non-small cell lung cancer
    Tepeli, Emre
    Caner, Vildan
    Buyukpinarbasili, Nur
    Cetin, G. Ozan
    Duzcan, Fusun
    Elmas, Levent
    Bagci, Gulseren
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (01) : 335 - 341
  • [10] ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer
    Li, Chunhong
    Liu, Meiyan
    Yan, An
    Liu, Wei
    Hou, Junjun
    Cai, Li
    Dong, Xiaoqun
    TUMOR BIOLOGY, 2014, 35 (12) : 12707 - 12712
12345